AU7263600A - Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases - Google Patents
Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseasesInfo
- Publication number
- AU7263600A AU7263600A AU72636/00A AU7263600A AU7263600A AU 7263600 A AU7263600 A AU 7263600A AU 72636/00 A AU72636/00 A AU 72636/00A AU 7263600 A AU7263600 A AU 7263600A AU 7263600 A AU7263600 A AU 7263600A
- Authority
- AU
- Australia
- Prior art keywords
- associated diseases
- prognosis
- diagnosis
- treatment
- trinucleotide repeat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 201000010099 disease Diseases 0.000 title 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 2
- 238000003745 diagnosis Methods 0.000 title 1
- 210000001739 intranuclear inclusion body Anatomy 0.000 title 1
- 238000004393 prognosis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15294199P | 1999-09-09 | 1999-09-09 | |
| US60152941 | 1999-09-09 | ||
| PCT/CA2000/001052 WO2001018544A1 (en) | 1999-09-09 | 2000-09-08 | Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7263600A true AU7263600A (en) | 2001-04-10 |
Family
ID=22545102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU72636/00A Abandoned AU7263600A (en) | 1999-09-09 | 2000-09-08 | Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1214597A1 (en) |
| AU (1) | AU7263600A (en) |
| CA (1) | CA2384146A1 (en) |
| WO (1) | WO2001018544A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003020977A2 (en) * | 2001-08-31 | 2003-03-13 | The University Court Of The University Of Glasgow | Nucleotide repeats assay |
| WO2006105038A2 (en) * | 2005-03-25 | 2006-10-05 | The Uab Research Foundation | Methods of altering gene expression and methods of treatment utilizing same |
| SG11201400125RA (en) * | 2011-09-19 | 2014-03-28 | Axon Neuroscience Se | Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2764611B1 (en) * | 1997-06-11 | 2002-02-01 | Fond Jean Dausset Ceph | REPEATED TRIPLET-RICH DNA SEQUENCES USEFUL IN THE DIAGNOSIS OF TRINUCLEOTIDE REPETITIVE DISEASES |
| CA2218199A1 (en) * | 1997-12-09 | 1999-06-09 | Mcgill University | Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof |
| CA2252727A1 (en) * | 1998-11-03 | 2000-05-03 | Ridha Joober | Polyglutamine containing proteins and use thereof for diagnosis and treatment of cag repeat-linked neuropsychiatric disorders |
-
2000
- 2000-09-08 WO PCT/CA2000/001052 patent/WO2001018544A1/en not_active Ceased
- 2000-09-08 CA CA002384146A patent/CA2384146A1/en not_active Abandoned
- 2000-09-08 AU AU72636/00A patent/AU7263600A/en not_active Abandoned
- 2000-09-08 EP EP00960253A patent/EP1214597A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2384146A1 (en) | 2001-03-15 |
| EP1214597A1 (en) | 2002-06-19 |
| WO2001018544A1 (en) | 2001-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001275177A1 (en) | Cardiac disease treatment and device | |
| AU2001253565A1 (en) | Cardiac disease treatment and device | |
| AU2001275176A1 (en) | Cardiac disease treatment and device | |
| AU2001281369A1 (en) | Cardiac disease treatment and device | |
| AU2002323258A1 (en) | Diagnosis and treatment of vascular disease | |
| GB9903841D0 (en) | Diagnosis and treatment of cancer | |
| AU2815900A (en) | Clinical and diagnostic database | |
| AU1967501A (en) | Device and method for improved diagnosis and treatment of cancer | |
| GB2368794B (en) | Prevention and treatment of amyloidogenic disease | |
| AU2002255248A1 (en) | Diagnosis, treatment and research of mental disorders | |
| AU5788300A (en) | Medical treatment method and kit | |
| AU2002367535A1 (en) | Diagnosis and treatment of vascular disease | |
| HUP0201205A2 (en) | Prevention and treatment of amyloidogenic disease | |
| AUPP784398A0 (en) | Kidney disease detection and treatment | |
| AU8026200A (en) | Treatment of heart disease with cox-2 inhibitors | |
| AU6425800A (en) | Agents for the diagnosis, prognosis and treatment of malignant diseases | |
| AU2002326813A1 (en) | Diagnosis and treatment of vascular disease | |
| AU2002341880A1 (en) | Diagnosis and treatment of vascular disease | |
| AU2003210266A1 (en) | Treatment, diagnosis and imaging of disease | |
| AU1238501A (en) | Process for consumer-directed diagnostic and health care information | |
| AU4654500A (en) | Prevention, diagnosis and treatment of lyme disease | |
| AU2002341604A1 (en) | Diagnosis and treatment of vascular disease | |
| GB9909392D0 (en) | Treatment, imaging and diagnosis of disease | |
| AU7263600A (en) | Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases | |
| AU2002330724A1 (en) | Diagnosis, prevention and treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |